Related Experiment Video
Updated: Jun 1, 2026

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
Published on: August 7, 2014
CCL5, CXCL16, and CX3CL1 are associated with Henoch-Schonlein purpura
Tao Chen1, Zai-Pei Guo, Xiao-Yan Jiao
1Department of Dermatovenereology, West China Hospital of Sichuan University, Chengdu, China.
Insights
Chemokines like CCL5, CXCL16, and CX3CL1 are elevated in Henoch-Schonlein purpura (HSP) patients and contribute to vascular inflammation. Active HSP sera induce chemokine production in endothelial cells via NF-κB and ERK pathways.
Area of Science:
- Vascular Biology
- Immunology
- Rheumatology
Background:
- Chemokines play a role in vascular inflammation.
- Limited data exists on chemokine involvement in Henoch-Schonlein purpura (HSP).
Purpose of the Study:
- To investigate serum levels of CCL5, CXCL16, and CX3CL1 in HSP patients.
- To assess the effect of HSP patient sera on chemokine production in human dermal microvascular endothelial cells (HMEC-1).
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) to measure serum chemokine levels.
- Treatment of HMEC-1 cells with sera from HSP patients, acute spontaneous urticaria patients, and controls.
- Analysis of chemokine mRNA and protein levels, cell migration, and intracellular signaling pathways (NF-κB, ERK).
Main Results:
- Serum CCL5, CXCL16, and CX3CL1 levels were elevated in acute HSP and correlated with disease severity.
- Sera from active HSP patients induced chemokine production in HMEC-1 cells.
- HSP sera-stimulated HMEC-1 cells enhanced leukocyte migration and activated NF-κB and ERK signaling pathways.
Conclusions:
- CCL5, CXCL16, and CX3CL1 are implicated in the pathogenesis of HSP.
- Factors in active HSP sera induce inflammatory responses in endothelial cells, promoting chemokine production via NF-κB and ERK pathways.
Abstract:
Chemokines are involved in the pathogenesis of various vascular inflammations. However, information about chemokines in Henoch-Schonlein purpura (HSP) is limited. Herein, we investigated the serum CCL5, CXCL16, and CX3CL1 levels in HSP patients with controls and the ability of sera from HSP patients on chemokine production in human dermal microvascular endothelial cells. Enzyme-linked immunosorbent assay (ELISA) detected serum CCL5, CXCL16, and CX3CL1 levels in patients with HSP. Human dermal microvascular endothelial cell line (HMEC-1) was treated with sera from patients with HSP at different stages, patients with acute spontaneous urticaria, or controls. Serum levels of CCL5, CXCL16, and CX3CL1 were elevated in HSP patients at acute stage, which correlated with the severity of this disease. Sera from patients with active HSP markedly induced CCL5, CXCL16, and CX3CL1 production at both mRNA and protein levels. In addition, patients' sera-stimulated HMEC-1 supernatants enhanced HL-60 or THP-1 cells migration. Furthermore, patients' sera increased the phosphorylation of inhibitor of κB-α (IκBα) and phosphorylation of extracellular signal-regulated kinase (ERK)1/2 protein levels, upregulated the translocation of nuclear factor-κB (NF-κB) p65 to the nucleus. Taken together, we show firstly that CCL5, CXCL16, and CX3CL1 may be involved in the pathogenesis of HSP. Factors present in sera from patients with active HSP may act as an inducer of inflammatory response in HMEC-1 cells and contribute to chemokine production through NF-κB and ERK 1/2 pathways.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Selectins
Inflammatory Bowel Disease III: Crohn's Disease
Hypersensitivity Reactions: Immune-Complex Reactions
Regulation of Hematopoietic Stem Cells
Hypersensitivity Reactions: Cytolytic Reactions

